{"article":{"annotation":{"article_id":"england-antibiotic-resistant-bacteraemia-2025-surveillance-2026","available_at":"2026-11-12T19:02:02.843455Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"1b21d01d913c1d01595b734051cfe9b35180a45e24f43d2eab811f444a0cb3cf","input_sha256":"07c69f384fba49450d0a787d36f9254e541969ab6eae442cb4b6886dd6df6ec3","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"GB","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.gov.uk/government/news/over-400-antibiotic-resistant-infections-each-week-in-2025","https://www.gov.uk/government/publications/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur/espaur-report-2025-to-2026-chapter-2-antimicrobial-resistance-amr"]}],"geometry":null,"id":"iso3166-1:GB","kind":"country-or-area","labels":{"ar":"المملكة المتحدة لبريطانيا العظمى وآيرلندا الشمالية","en":"United Kingdom of Great Britain and Northern Ireland","es":"Reino Unido de Gran Bretaña e Irlanda del Norte","fr":"Royaume-Uni de Grande-Bretagne et d’Irlande du Nord"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.gov.uk/government/news/over-400-antibiotic-resistant-infections-each-week-in-2025","https://www.gov.uk/government/publications/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur/espaur-report-2025-to-2026-chapter-2-antimicrobial-resistance-amr"]}],"method":"controlled-rules-v1","rule_id":"health-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=en","category":"health","content":{"key_points":[],"paragraphs":["The UK Health Security Agency reported 21,129 antibiotic-resistant bacteraemia cases in 2025, equivalent to an average of 406 cases a week. Bacteraemia means bacteria are present in the bloodstream and can be life-threatening. The figure is not a count of every antibiotic-resistant infection in England, nor does it mean all affected people died. It is a surveillance measure for resistant bloodstream infections, and its scope should remain clear when comparing it with other health statistics.","The total was 16.8 per cent higher than the 18,086 cases recorded in 2019. The pace of increase slowed in the latest year: cases rose 3.2 per cent from 20,468 in 2024, compared with a 9.3 per cent rise from 18,732 in 2023. A slower increase is not a decline. The latest annual count remains higher than the previous year and substantially above the 2019 baseline used in the report.","The data show that resistance continued to rise even as antibiotic use in the NHS fell. Total NHS antibiotic consumption decreased 10.7 per cent between 2019 and 2025, from 17.8 to 15.9 defined daily doses per 1,000 inhabitants per day. Private prescriptions dispensed in community pharmacies, which are not included in that NHS measure, fell 20.8 per cent between 2024 and 2025. These measures have different coverage and time periods, and changes in consumption do not translate mechanically into immediate changes in resistant infection rates.","UKHSA also reported an estimate of 2,318 deaths in 2025 among people with resistant Gram-negative bacteraemia, broadly level with 2,399 in 2024. This is a count of deaths among people with the infection, not an estimate that resistance alone caused each death. The agency's summary says further work is underway to quantify costs directly attributable to infection and resistance. A preliminary analysis estimated around 53,400 hospital admissions related to Gram-negative bloodstream infection cost NHS hospitals about £800 million between 2023 and 2024, but that estimate is not a full attribution of cost to resistance.","Age and deprivation patterns point to unequal exposure. Adults over 45 accounted for 89.3 per cent of resistant infection cases, and people over 74 accounted for 49.7 per cent. UKHSA notes that age is associated with multiple health conditions and greater exposure to healthcare and medical interventions. People in the most deprived areas had a 44.2 per cent higher rate of resistant bacteraemia than those in the least deprived areas, at 44.4 compared with 30.8 cases per 100,000 people. Those are population rates, not individual risk predictions.","The report also describes differences by ethnic group and by Integrated Care Board area. The observed rates vary substantially, but the figures do not explain the causes of those differences. UKHSA says it is working with partners to understand them. Differences in health status, care access, testing practices, population structure and exposure may require further analysis before a causal explanation can be made. The release should not be read as evidence that ethnicity itself causes infection or resistance.","The findings reinforce that stewardship is only one part of reducing antimicrobial resistance. Appropriate prescribing can help slow selection pressure, but infection prevention, vaccination, diagnosis, hospital practice and access to effective treatments also matter. UKHSA's own statement says reduced use alone is insufficient. The agency's 2024 to 2029 national action plan provides the policy framework, while the annual surveillance report tracks selected outcomes and prescribing measures.","The verified picture is a persistently elevated number of resistant bloodstream infections, a slower year-on-year increase, lower reported NHS antibiotic consumption and marked differences across age and deprivation groups. The data do not establish why each trend changed or how much of the death and hospital cost burden is directly attributable to resistance. Future releases should be assessed against consistent definitions and coverage, with attention to both infection prevention and responsible antibiotic use."],"sections":[]},"corrections":[],"country":"GB","data":{"blocks":[{"description":{"ar":"أرقام مختارة منقولة من المصدر الأولي المشار إليه.","de":"Ausgewählte Zahlen aus der zitierten Primärquelle.","en":"Selected figures transcribed from the cited primary source.","es":"Cifras seleccionadas transcritas de la fuente primaria citada.","fr":"Chiffres sélectionnés transcrits de la source primaire citée.","pt":"Valores selecionados transcritos da fonte primária citada.","tr":"Atıf yapılan birincil kaynaktan aktarılan seçilmiş rakamlar."},"id":"reported-figures","items":[{"basis":"observed","label":{"ar":"حالات تجرثم الدم المقاوم للمضادات الحيوية","de":"Fälle antibiotikaresistenter Bakteriämie","en":"Antibiotic-resistant bacteraemia cases","es":"Casos de bacteriemia resistente a antibióticos","fr":"Cas de bactériémie résistante aux antibiotiques","pt":"Casos de bacteriemia resistente a antibióticos","tr":"Antibiyotiğe dirençli bakteriyemi vakaları"},"measure":{"aggregation":"unspecified","frequency":"annual","geography":"england","id":"part54-england-antibiotic-resistant-bacteraemia-2025-surveillance-2026-1","periodRole":"reference-period","unitCode":"count"},"period":"2025","unit":"count","value":21129},{"basis":"observed","label":{"ar":"التغير في حالات تجرثم الدم المقاوم مقارنة بعام 2024","de":"Veränderung der Fälle resistenter Bakteriämie gegenüber 2024","en":"Change in resistant bacteraemia cases from 2024","es":"Variación de los casos de bacteriemia resistente desde 2024","fr":"Variation des cas de bactériémie résistante par rapport à 2024","pt":"Variação dos casos de bacteriemia resistente desde 2024","tr":"2024’ten bu yana dirençli bakteriyemi vakalarındaki değişim"},"measure":{"aggregation":"change","frequency":"annual","geography":"england","id":"part54-england-antibiotic-resistant-bacteraemia-2025-surveillance-2026-2","periodRole":"reference-period","unitCode":"percent"},"period":"2025","periodStart":"2024","unit":"percent","value":3.2},{"basis":"observed","label":{"ar":"التغير في استخدام المضادات الحيوية في هيئة الخدمات الصحية الوطنية من 2019 إلى 2025","de":"Veränderung des Antibiotikaverbrauchs des NHS von 2019 bis 2025","en":"NHS antibiotic use change from 2019 to 2025","es":"Variación del uso de antibióticos del NHS de 2019 a 2025","fr":"Évolution de l’usage des antibiotiques par le NHS entre 2019 et 2025","pt":"Variação do uso de antibióticos no NHS entre 2019 e 2025","tr":"2019-2025 arasında NHS antibiyotik kullanımındaki değişim"},"measure":{"aggregation":"change","frequency":"annual","geography":"england","id":"part54-england-antibiotic-resistant-bacteraemia-2025-surveillance-2026-3","periodRole":"reference-period","unitCode":"percent"},"period":"2025","periodStart":"2019","unit":"percent","value":-10.7},{"basis":"observed","label":{"ar":"ارتفاع معدل تجرثم الدم المقاوم في المناطق الأشد حرماناً","de":"Höhere Rate resistenter Bakteriämie in den am stärksten benachteiligten Gebieten","en":"Higher resistant bacteraemia rate in most deprived areas","es":"Tasa más alta de bacteriemia resistente en las zonas más desfavorecidas","fr":"Hausse du taux de bactériémie résistante dans les zones les plus défavorisées","pt":"Taxa mais elevada de bacteriemia resistente nas áreas mais desfavorecidas","tr":"En yoksun bölgelerde dirençli bakteriyemi oranının yüksekliği"},"measure":{"aggregation":"rate","frequency":"annual","geography":"england","id":"part54-england-antibiotic-resistant-bacteraemia-2025-surveillance-2026-4","periodRole":"reference-period","unitCode":"percent"},"period":"2025","unit":"percent","value":44.2}],"methodology":{"ar":"تحتفظ الأرقام بالفترة والسكان والنطاق والتعريفات التي يحددها المصدر. وتُصنف الأهداف المعلنة والتقديرات والتوقعات والحدود العليا بحسب أساسها. ولا تُستنتج أي قيمة مفقودة.","de":"Die Zahlen behalten den in der Quelle angegebenen Zeitraum, die Bezugsgröße, den Umfang und die Definitionen bei. Angekündigte Ziele, Schätzungen, Prognosen und Obergrenzen sind nach ihrer Grundlage gekennzeichnet. Fehlende Werte werden nicht abgeleitet.","en":"Figures retain the source's stated period, population, scope and definitions. Announced targets, estimates, forecasts and upper bounds are labeled by basis. No missing value is inferred.","es":"Las cifras conservan el periodo, la población, el alcance y las definiciones indicados por la fuente. Los objetivos anunciados, estimaciones, previsiones y límites máximos se identifican según su base. No se infiere ningún valor ausente.","fr":"Les chiffres conservent la période, la population, le périmètre et les définitions indiqués par la source. Les objectifs annoncés, estimations, prévisions et plafonds sont qualifiés selon leur base. Aucune valeur manquante n’est déduite.","pt":"Os valores mantêm o período, a população, o âmbito e as definições indicados pela fonte. Metas anunciadas, estimativas, previsões e limites superiores são identificados segundo a respetiva base. Nenhum valor em falta é inferido.","tr":"Rakamlar kaynağın belirttiği dönem, nüfus, kapsam ve tanımları korur. Açıklanan hedefler, tahminler, öngörüler ve üst sınırlar dayanaklarına göre etiketlenir. Eksik değerler çıkarımla tamamlanmaz."},"sourceUrls":["https://www.gov.uk/government/news/over-400-antibiotic-resistant-infections-each-week-in-2025","https://www.gov.uk/government/publications/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur/espaur-report-2025-to-2026-chapter-2-antimicrobial-resistance-amr"],"title":{"ar":"الأرقام الرئيسية المعلنة","de":"Wichtige gemeldete Kennzahlen","en":"Key reported figures","es":"Cifras clave comunicadas","fr":"Principaux chiffres déclarés","pt":"Principais valores reportados","tr":"Bildirilen temel rakamlar"},"type":"metrics","updatedAt":"2026-11-12T18:51:25Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026/data/reported-figures?lang=en&format=csv","json":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026/data/reported-figures?lang=en&format=json"},"id":"reported-figures"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-6089cb15-6258-5e5d-9a23-4341c1af2bff","event_period":"2025","event_period_basis":"event-or-reference-period","id":"england-antibiotic-resistant-bacteraemia-2025-surveillance-2026","image":null,"importance":0.6,"language":"en","modified_at":"2026-11-12T19:01:55+00:00","publication_basis":"publication-record","published_at":"2026-11-12T19:01:55+00:00","reading_minutes":4,"region":"world","relations":[],"section_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"england-antibiotic-resistant-bacteraemia-2025-surveillance-2026","sources":[{"checkedAt":"2026-11-12","name":"UK Health Security Agency, Over 400 antibiotic-resistant infections each week in 2025","publishedAt":"2026-11-12","url":"https://www.gov.uk/government/news/over-400-antibiotic-resistant-infections-each-week-in-2025"},{"checkedAt":"2026-11-12","name":"UK Health Security Agency, ESPAUR report 2025 to 2026, Chapter 2: Antimicrobial resistance","publishedAt":"2026-11-12","url":"https://www.gov.uk/government/publications/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur/espaur-report-2025-to-2026-chapter-2-antimicrobial-resistance-amr"}],"summary":"UKHSA surveillance recorded 21,129 antibiotic-resistant bacteraemia cases in 2025, 16.8% above 2019, although the annual increase slowed to 3.2%. NHS antibiotic use fell over the period, showing that lower use alone has not reversed the reported resistance burden.","text":"UKHSA surveillance recorded 21,129 antibiotic-resistant bacteraemia cases in 2025, 16.8% above 2019, although the annual increase slowed to 3.2%. NHS antibiotic use fell over the period, showing that lower use alone has not reversed the reported resistance burden.\n\nThe UK Health Security Agency reported 21,129 antibiotic-resistant bacteraemia cases in 2025, equivalent to an average of 406 cases a week. Bacteraemia means bacteria are present in the bloodstream and can be life-threatening. The figure is not a count of every antibiotic-resistant infection in England, nor does it mean all affected people died. It is a surveillance measure for resistant bloodstream infections, and its scope should remain clear when comparing it with other health statistics.\n\nThe total was 16.8 per cent higher than the 18,086 cases recorded in 2019. The pace of increase slowed in the latest year: cases rose 3.2 per cent from 20,468 in 2024, compared with a 9.3 per cent rise from 18,732 in 2023. A slower increase is not a decline. The latest annual count remains higher than the previous year and substantially above the 2019 baseline used in the report.\n\nThe data show that resistance continued to rise even as antibiotic use in the NHS fell. Total NHS antibiotic consumption decreased 10.7 per cent between 2019 and 2025, from 17.8 to 15.9 defined daily doses per 1,000 inhabitants per day. Private prescriptions dispensed in community pharmacies, which are not included in that NHS measure, fell 20.8 per cent between 2024 and 2025. These measures have different coverage and time periods, and changes in consumption do not translate mechanically into immediate changes in resistant infection rates.\n\nUKHSA also reported an estimate of 2,318 deaths in 2025 among people with resistant Gram-negative bacteraemia, broadly level with 2,399 in 2024. This is a count of deaths among people with the infection, not an estimate that resistance alone caused each death. The agency's summary says further work is underway to quantify costs directly attributable to infection and resistance. A preliminary analysis estimated around 53,400 hospital admissions related to Gram-negative bloodstream infection cost NHS hospitals about £800 million between 2023 and 2024, but that estimate is not a full attribution of cost to resistance.\n\nAge and deprivation patterns point to unequal exposure. Adults over 45 accounted for 89.3 per cent of resistant infection cases, and people over 74 accounted for 49.7 per cent. UKHSA notes that age is associated with multiple health conditions and greater exposure to healthcare and medical interventions. People in the most deprived areas had a 44.2 per cent higher rate of resistant bacteraemia than those in the least deprived areas, at 44.4 compared with 30.8 cases per 100,000 people. Those are population rates, not individual risk predictions.\n\nThe report also describes differences by ethnic group and by Integrated Care Board area. The observed rates vary substantially, but the figures do not explain the causes of those differences. UKHSA says it is working with partners to understand them. Differences in health status, care access, testing practices, population structure and exposure may require further analysis before a causal explanation can be made. The release should not be read as evidence that ethnicity itself causes infection or resistance.\n\nThe findings reinforce that stewardship is only one part of reducing antimicrobial resistance. Appropriate prescribing can help slow selection pressure, but infection prevention, vaccination, diagnosis, hospital practice and access to effective treatments also matter. UKHSA's own statement says reduced use alone is insufficient. The agency's 2024 to 2029 national action plan provides the policy framework, while the annual surveillance report tracks selected outcomes and prescribing measures.\n\nThe verified picture is a persistently elevated number of resistant bloodstream infections, a slower year-on-year increase, lower reported NHS antibiotic consumption and marked differences across age and deprivation groups. The data do not establish why each trend changed or how much of the death and hospital cost burden is directly attributable to resistance. Future releases should be assessed against consistent definitions and coverage, with attention to both infection prevention and responsible antibiotic use.","title":"England records 21,129 antibiotic-resistant bloodstream infection episodes in 2025","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"},{"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"},{"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"},{"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"},{"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"},{"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"},{"api_url":"https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"}],"url":"https://newsverum.com/en/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026"},"version":"1"}
